Zydus Lifesciences announced a 35.9% year-on-year decline in its consolidated net profit, which reached ₹940 crore for the June quarter compared to ₹1,467 crore during the same period last year. While operational revenue grew by 22% to hit ₹8,017 crore, the company's EBITDA fell by 7.6% to ₹1,930 crore, resulting in an EBITDA margin of 24.1%.

by shortkt.com✓

5 hours ago